Clincosm LogoSign in Get a demo

Hepatocellular Carcinoma

Showing NaN - NaN of 56
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma, Colorectal Cancer Trial in Hong Kong (Patient-Derived Tumor Organoids)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Colorectal Cancer
  • Patient-Derived Tumor Organoids
  • Hong Kong, N.t., Hong Kong
    Endoscopy Centre, Prince of Wales Hospital
Oct 12, 2023

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023

Hepatocellular Carcinoma, Biliary Tract Cancer Trial in Worldwide (MEDI5752, Bevacizumab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Biliary Tract Cancer
  • Birmingham, Alabama
  • +44 more
Mar 17, 2023

Hepatocellular Carcinoma Trial in Worldwide (Nivolumab, Ipilimumab, Sorafenib)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Tucson, Arizona
  • +209 more
Jan 17, 2023

OREIOS International Study

Recruiting
  • Hepatocellular Carcinoma
    • Alexandira, Egypt
    • +21 more
    Jan 11, 2023

    Hepatocellular Carcinoma Trial in Worldwide (drug, other, procedure)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • Mobile, Alabama
    • +182 more
    Dec 1, 2022

    Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Worldwide (Nivolumab, Relatlimab)

    Recruiting
    • Hepatocellular Carcinoma
    • +4 more
    • Nivolumab
    • Relatlimab
    • Ciudad de Buenos Aires, Buenos Aires, Argentina
    • +74 more
    Nov 11, 2022

    Hepatocellular Carcinoma Trial in Hong Kong (TACE)

    Recruiting
    • Hepatocellular Carcinoma
    • TACE
    • Hong Kong, Hong Kong
      Department of Imaging and Interventional Radiology, Prince of Wa
    Oct 19, 2022

    Hepatocellular Carcinoma Trial in Worldwide (Durvalumab, Bevacizumab, Placebo)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • Birmingham, Alabama
    • +213 more
    Aug 19, 2022

    Hepatocellular Carcinoma, HCC, Liver Cancer Trial in Hong Kong (Nivolumab, Hepatectomy)

    Completed
    • Hepatocellular Carcinoma
    • +2 more
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Jul 20, 2022

    Hepatocellular Carcinoma Trial in Worldwide (Tremelimumab, Durvalumab, Bevacizumab)

    Active, not recruiting
    Has Results
    • Hepatocellular Carcinoma
    • Tremelimumab
    • +2 more
    • Phoenix, Arizona
    • +43 more
    Jun 22, 2022

    Hepatitis B, Hepatocellular Carcinoma Trial in Zhengzhou, Hong Kong (Nurse-led decision counseling, Usual care)

    Completed
    • Hepatitis B
    • Hepatocellular Carcinoma
    • Nurse-led decision counseling
    • Usual care
    • Zhengzhou, Henan, China
    • +1 more
    Mar 27, 2022

    Hepatocellular Carcinoma Trial in Worldwide (Durvalumab, Tremelimumab (Regimen 1), Tremelimumab (Regimen 2))

    Recruiting
    • Hepatocellular Carcinoma
    • Los Angeles, California
    • +173 more
    Mar 25, 2022

    Hepatocellular Carcinoma Trial in Hong Kong (Microwave ablation, Radiofrequency ablation)

    Completed
    • Hepatocellular Carcinoma
    • Microwave ablation
    • Radiofrequency ablation
    • Hong Kong, China
      Prince of Wales Hospital
    Mar 5, 2022

    Hepatocellular Carcinoma Trial in Hong Kong (Transarterial chemoembolisation using cisplatin-lipiodol mixture)

    Completed
    • Hepatocellular Carcinoma
    • Transarterial chemoembolisation using cisplatin-lipiodol mixture
    • Hong Kong, China
      Prince of Wales Hospital
    Mar 5, 2022

    Hepatocellular Carcinoma Trial in Hong Kong (Pringle)

    Completed
    • Hepatocellular Carcinoma
    • Pringle
    • Hong Kong, China
      The Prince of Wales Hospital
    Mar 5, 2022

    Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Sorafenib, Lenvatinib)

    Recruiting
    • Hepatocellular Carcinoma
    • Hong Kong, Hong Kong SAR, Hong Kong
      Humanity & Health Research Centre
    Mar 16, 2022

    The Overall Survival of Unresectable HCC in Real-life

    Recruiting
    • Hepatocellular Carcinoma
      • Beijing, China
      • +2 more
      Mar 16, 2022

      Hepatocellular Carcinoma Trial in Hong Kong (Cisplatin)

      Recruiting
      • Hepatocellular Carcinoma
      • Hong Kong, Hong Kong
        Department of Imaging and Interventional Radiology, Prince of Wa
      Mar 10, 2022

      Hepatocellular Carcinoma Trial in Hong Kong (The balloon catheter is placed at the various arterial feeders of the tumor)

      Recruiting
      • Hepatocellular Carcinoma
      • The balloon catheter is placed at the various arterial feeders of the tumor
      • Hong Kong, Hong Kong
        Department of Imaging and Interventional Radiology, Prince of Wa
      Mar 10, 2022

      Hepatocellular Carcinoma Trial in Hong Kong (Open or laparoscopic surgery)

      Recruiting
      • Hepatocellular Carcinoma
      • Open or laparoscopic surgery
      • Hong Kong, Hong Kong
        Chinese University of Hong Kong
      Feb 27, 2022

      Hepatocellular Carcinoma Trial in Hong Kong (Radiofrequency ablation or microwave ablation)

      Recruiting
      • Hepatocellular Carcinoma
      • Radiofrequency ablation or microwave ablation
      • Hong Kong, Hong Kong
        Chinese University of Hong Kong
      Feb 27, 2022

      Hepatocellular Carcinoma Trial in Worldwide (LY2157299, Sorafenib, Placebo)

      Completed
      Has Results
      • Hepatocellular Carcinoma
      • Beijing, China
      • +15 more
      Feb 14, 2022

      Hepatocellular Carcinoma Trial in Worldwide (Ramucirumab, Placebo)

      Completed
      Has Results
      • Hepatocellular Carcinoma
      • Daly City, California
      • +130 more
      Jan 5, 2022

      Hepatocellular Carcinoma Trial in Worldwide (Nivolumab, Sorafenib, Ipilimumab)

      Active, not recruiting
      • Hepatocellular Carcinoma
      • Nivolumab
      • +3 more
      • Los Angeles, California
      • +58 more
      Dec 1, 2021